drugset / Trial / NCT05042102

Donepezil and Cognitive Training for Alcohol Use Disorder (AUD)

NCT05042102

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The goal of the project is to evaluate whether donepezil + cognitive remediation therapy is superior to placebo in reducing heavy drinking in patients with alcohol use disorder in a double-blind, placebo-controlled trial.

Timeline

Start
2022-08-08
Primary completion
2026-10-31
Completion
2026-10-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Donepezil Small molecule 10 mg Oral